Anticoagulant Clinical Trial
Official title:
Evaluation of Patient's Knowledge of Their NACO Treatment
| Verified date | February 2018 |
| Source | Groupe Hospitalier Paris Saint Joseph |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
More than one million of patient receive anti vitamine K treatment which is the main cause of
hospitalization. About 50 000 patient receive direct oral anticoagulant .
The aim is to evaluate the patient's level of knowledge about their anticoagulant treatment
and specially about the side effect
| Status | Completed |
| Enrollment | 51 |
| Est. completion date | November 1, 2017 |
| Est. primary completion date | March 31, 2017 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - patient with AOD treatment - capable to answer to questionnaire - with or without antivitamin K Exclusion Criteria: - dementia - cognitive trouble - refusing participation |
| Country | Name | City | State |
|---|---|---|---|
| France | Groupe Hospitalier Paris Saint Joseph | Paris | Ile-de-France |
| Lead Sponsor | Collaborator |
|---|---|
| Groupe Hospitalier Paris Saint Joseph |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | questionnaire score >80% | it's a questionnaire about anticoagulant treatment ; each question has a score ans for the study investigators calculate the total | Day 1 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04010955 -
Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)
|
||
| Recruiting |
NCT04673695 -
A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344
|
Phase 1 | |
| Completed |
NCT03893591 -
A Prospective Study to Examine the Need to Adjust the Dose of Apixaban When Used in Atrial Fibrillation and Obesity
|
||
| Completed |
NCT03895502 -
Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study
|
Phase 4 | |
| Completed |
NCT03154489 -
Effectiveness of a Multidisciplinary Medication Review With Follow-up for Patients Treated With Coumarin Anticoagulants in Primary Care
|
N/A | |
| Completed |
NCT04305821 -
Medico-economic Interest of the Protein S100b in Mild Head Trauma Under Anti-thrombotics
|
||
| Recruiting |
NCT06020560 -
Study of Low Molecular Weight Heparins
|
Phase 4 | |
| Not yet recruiting |
NCT05788900 -
Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Intravenous Administration
|
Phase 1 | |
| Not yet recruiting |
NCT05788913 -
Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Subcutaneous Administration
|
Phase 1 | |
| Terminated |
NCT03172546 -
Determinants of Oral Anticoagulants' Activity
|
||
| Not yet recruiting |
NCT04592822 -
A Single Dose Bioequivalence Study of WD-1602 Versus Pradaxa® in Healthy Subjects Under Fed Condition
|
Phase 1 | |
| Recruiting |
NCT03772457 -
Predictive Value of Infarction Volume on Hemorrhagic Transformation in Ischemic Stroke/TIA With Non-valve Atrial Fibrillation(NVAF) Patients Using Rivaroxaban
|
||
| Recruiting |
NCT04257487 -
Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)
|
Phase 3 | |
| Completed |
NCT04272723 -
Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine Physicians
|
||
| Recruiting |
NCT04867200 -
A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers
|
Phase 1 |